The current valuation score of Organogenesis Holdings Inc is 8.85, ranking 46 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -21.45, which is -655.58% below the recent high of 119.16 and -3966.54% above the recent low of -872.19.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.